Latest Regulatory Milestones News

Caravel Minerals has made significant strides in advancing its Caravel Copper Project, initiating its Definitive Feasibility Study and securing critical funding amid a tightening copper market.

Variscan Mines secures key regulatory approval and expands its zinc exploration footprint with a major historic drillhole acquisition, backed by a $2.25 million capital raise.

Santana Minerals reports robust progress on its Bendigo-Ophir Gold Project with an updated Pre-Feasibility Study, strategic land acquisitions, and a substantial capital raise, positioning the project for development in 2026.

European Metals Holdings has advanced its Cinovec Lithium Project with a new preliminary mining permit and secured funding to complete its Definitive Feasibility Study, reinforcing its position in Europe's critical raw materials landscape.

EMVision Medical Devices has successfully closed an oversubscribed Share Purchase Plan, raising $2 million and bringing total recent capital to $14 million. This funding positions the company to advance pivotal clinical trials and regulatory milestones for its innovative neurodiagnostic devices.

Blue Energy has been granted a critical petroleum lease in Queensland and completed a $5.8 million capital raise, positioning itself to meet rising gas demand aligned with the Queensland Government’s new Energy Roadmap.

Memphasys has sharpened its commercial focus on the Felix™ System, securing a major distribution expansion in the MENA region and cutting operational costs by 40%, setting the stage for a global market push.

Australian Vanadium Limited advances its vertically integrated vanadium strategy with key regulatory approvals, manufacturing expansions, and a new $10 million loan facility, positioning itself for major energy storage projects.

Bubs Australia reported a 30% increase in net revenue to $25.6 million for Q1 FY26, driven by robust US sales and a return to profitability with positive EBITDA. Despite inventory challenges in other regions, the company maintains a solid cash position and anticipates FDA approval by year-end.

Percheron Therapeutics reports encouraging phase I clinical results for HMBD-002, confirming safety and early efficacy signals, while gearing up for a multi-arm phase II trial in 2026.

Globe Metals & Mining advances its Kanyika Niobium Project with a regulatory extension, licence expansion to new critical minerals, and a significant capital raise, positioning the company for its next development phase.

Cobre Limited has reported a maiden Mineral Resource Estimate for its Ngami Copper Project in Botswana, alongside a significant investment agreement with Sinomine International Exploration. The company also advanced exploration activities with BHP funding and progressed key permitting milestones.